Upcoming event
Celebrate Mother’s Day with a life-saving gift for all women in Michigan with a donation to MIOCA. And watch for further details about upcoming Mother's Day events throughout the month of May at Breath of Spring Florist in Bloomfield Hills, The Little Shoppe in Garden City and Mary Kay Beauty Consultant, Charlie Long-Graham.
Despite a weekend of spring storms, MIOCA’s Team Teal raised ovarian cancer awareness throughout the streets of Ann Arbor in the 2012 Big House / Big Heart race. With one of the largest charity teams of the nearly 200 organizations participating, we also had great visibility at the preceding day’s health expo, where the 10,000-plus event attendees registered. Many Team Teal members raced in honor or memory of loved ones, wearing personally decorated race tags on their award winning MIOCA t-shirt. So a huge thank you to all the teal-clad racers, expo volunteers and our many wonderful supporters for making this year’s event a tremendous success.
However, it's still not too late to support the team with your tax deductible donation. Please SUPPORT TEAM TEAL here. Thank you.
Established in 2011, the Michigan Ovarian Cancer Alliance promotes saving women’s lives through the early detection of ovarian cancer and improved treatment outcomes. In addition to community outreach and education, MIOCA provides advocacy, resources and support throughout Michigan.
|
NCCN PUBLISHES NEW TREATMENT GUIDELINES
The National Comprehensive Cancer Network (NCCN) just published three updated ovarian cancer guidelines. The guidelines are based on research evidence from clinical trials and other studies. They are developed by oncologists from an alliance of twenty-one highly respected cancer centers and are one component of a physician’s treatment recommendations for a patient. |
|
|
Olaparib shows improvement in PFS but not OS, So Far
Olaparib, a PARP inhibitor, showed a 3.6 month improvement in progression free survival (PFS) in women with platinum sensitive recurrent ovarian cancer. However, based on the interim analsis, there is no significant improvement in overall survival. PARP inhibitors are presumed to work particularly well for patients with a BRCA mutation, however BRCA status was not required for enrollment in this trial. |
|
Tell Us How Ovarian Cancer Drug Shortages Are Affecting YouDrug shortages are affecting patient care across the United States. Many of the medications in short supply are chemotherapy drugs, nutritional supplements and anesthesia drugs. The cause of these shortages is not fully known, but the effect on patients is clear. Ovarian cancer patients have had reduced access to surgeries and critical drugs needed for treatment. Many women cannot receive standard therapies safely and on time. Many of the standard treatments for ovarian cancer are not available; if women can get drugs, they may not be the standard of care, they may not be available at the right time, or they may be more expensive or less effective drugs. This is unacceptable. MIOCA is working with the Ovarian Cancer National Alliance and the American Cancer Society to remedy this situation. But we need your help to show our legislators and regulators how drug shortages are affecting women with ovarian cancer. Your stories can persuade and pressure them to act on behalf of patients and put an end to these critical drug shortages. Please contact us to share your story. reprinted, in part, from OCNA all actions |
